Literature DB >> 14748001

Predicting peptide binding to MHC pockets via molecular modeling, implicit solvation, and global optimization.

Heather D Schafroth1, Christodoulos A Floudas.   

Abstract

Development of a computational prediction method based on molecular modeling, global optimization, and implicit solvation has produced accurate structure and relative binding affinity predictions for peptide amino acids binding to five pockets of the MHC molecule HLA-DRB1*0101. Because peptide binding to MHC molecules is essential to many immune responses, development of such a method for understanding and predicting the forces that drive binding is crucial for pharmaceutical design and disease treatment. Underlying the development of this prediction method are two hypotheses. The first is that pockets formed by the peptide binding groove of MHC molecules are independent, separating the prediction of peptide amino acids that bind within individual pockets from those that bind between pockets. The second hypothesis is that the native state of a system composed of an amino acid bound to a protein pocket corresponds to the system's lowest free energy. The prediction method developed from these hypotheses uses atomistic-level modeling, deterministic global optimization, and three methods of implicit solvation: solvent-accessible area, solvent-accessible volume, and Poisson-Boltzmann electrostatics. The method predicts relative binding affinities of peptide amino acids for pockets of HLA-DRB1*0101 by determining computationally an amino acid's global minimum energy conformation. Prediction results from the method are in agreement with X-ray crystallography data and experimental binding assays. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14748001     DOI: 10.1002/prot.10608

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  8 in total

Review 1.  MHC class II epitope predictive algorithms.

Authors:  Morten Nielsen; Ole Lund; Søren Buus; Claus Lundegaard
Journal:  Immunology       Date:  2010-04-12       Impact factor: 7.397

2.  Limitations of Ab initio predictions of peptide binding to MHC class II molecules.

Authors:  Hao Zhang; Peng Wang; Nikitas Papangelopoulos; Ying Xu; Alessandro Sette; Philip E Bourne; Ole Lund; Julia Ponomarenko; Morten Nielsen; Bjoern Peters
Journal:  PLoS One       Date:  2010-02-17       Impact factor: 3.240

3.  Design of enhanced agonists through the use of a new virtual screening method: application to peptides that bind class I major histocompatibility complex (MHC) molecules.

Authors:  Sergio Madurga; Ignasi Belda; Xavier Llorà; Ernest Giralt
Journal:  Protein Sci       Date:  2005-08       Impact factor: 6.725

4.  Molecular modeling of class I and II alleles of the major histocompatibility complex in Salmo salar.

Authors:  Constanza Cárdenas; Axel Bidon-Chanal; Pablo Conejeros; Gloria Arenas; Sergio Marshall; F Javier Luque
Journal:  J Comput Aided Mol Des       Date:  2010-10-10       Impact factor: 3.686

5.  Towards universal structure-based prediction of class II MHC epitopes for diverse allotypes.

Authors:  Andrew J Bordner
Journal:  PLoS One       Date:  2010-12-20       Impact factor: 3.240

6.  Variations in the electrostatic landscape of class II human leukocyte antigen molecule induced by modifications in the myelin basic protein peptide: a theoretical approach.

Authors:  William A Agudelo; Johan F Galindo; Marysol Ortiz; José L Villaveces; Edgar E Daza; Manuel E Patarroyo
Journal:  PLoS One       Date:  2009-01-09       Impact factor: 3.240

7.  Ionic channels as targets for drug design: a review on computational methods.

Authors:  Gregorio Fernández-Ballester; Asia Fernández-Carvajal; José Manuel González-Ros; Antonio Ferrer-Montiel
Journal:  Pharmaceutics       Date:  2011-12-09       Impact factor: 6.321

8.  DockTope: a Web-based tool for automated pMHC-I modelling.

Authors:  Maurício Menegatti Rigo; Dinler Amaral Antunes; Martiela Vaz de Freitas; Marcus Fabiano de Almeida Mendes; Lindolfo Meira; Marialva Sinigaglia; Gustavo Fioravanti Vieira
Journal:  Sci Rep       Date:  2015-12-17       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.